Literature DB >> 32109960

Standardization and Updating of a Drug Allergy Testing Program: The McGill Experience and Impact on Pharmacy Activities.

Gilbert Matte1, Joseph Shuster2, Chantal Guevremont3, Phil Gold2, Fabrice Leong4, Zinquon Ngan5, André Bonnici3, Chris Tsoukas2.   

Abstract

Entities:  

Year:  2020        PMID： 32109960      PMCID： PMC7023931     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  23 in total

1.  Allergy diagnostic testing: an updated practice parameter.

Authors:  I Leonard Bernstein; James T Li; David I Bernstein; Robert Hamilton; Sheldon L Spector; Ricardo Tan; Scott Sicherer; David B K Golden; David A Khan; Richard A Nicklas; Jay M Portnoy; Joann Blessing-Moore; Linda Cox; David M Lang; John Oppenheimer; Christopher C Randolph; Diane E Schuller; Stephen A Tilles; Dana V Wallace; Estelle Levetin; Richard Weber
Journal:  Ann Allergy Asthma Immunol       Date:  2008-03       Impact factor: 6.347

2.  Impact of persistent β-lactam allergy documentation despite delabeling in the perioperative setting.

Authors:  Yara Moussa; Andrew Sullivan; Gilbert Matte; Robert H Goldstein; Gabriele Baldini; Joseph Shuster; Christos Tsoukas
Journal:  J Allergy Clin Immunol Pract       Date:  2019-07-08

3.  The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital.

Authors:  K Sade; I Holtzer; Y Levo; S Kivity
Journal:  Clin Exp Allergy       Date:  2003-04       Impact factor: 5.018

Review 4.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 5.  Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation.

Authors:  Kimberly G Blumenthal; Erica S Shenoy; Anna R Wolfson; David N Berkowitz; Victoria A Carballo; Diana S Balekian; Kathleen A Marquis; Ramy Elshaboury; Ronak G Gandhi; Praveen Meka; David W Kubiak; Jennifer Catella; Barbara B Lambl; Joyce T Hsu; Monique M Freeley; Alana Gruszecki; Paige G Wickner
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

6.  Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review.

Authors:  Melissa Iammatteo; Kimberly G Blumenthal; Rebecca Saff; Aidan A Long; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2014-09-10

7.  Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity.

Authors:  A-M Chiriac; T Rerkpattanapipat; P-J Bousquet; N Molinari; P Demoly
Journal:  Allergy       Date:  2016-11-23       Impact factor: 13.146

8.  BSACI guidelines for the management of drug allergy.

Authors:  R Mirakian; P W Ewan; S R Durham; L J F Youlten; P Dugué; P S Friedmann; J S English; P A J Huber; S M Nasser
Journal:  Clin Exp Allergy       Date:  2009-01       Impact factor: 5.018

9.  Appropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service Consult.

Authors:  Bryan G Shaw; Inela Masic; Nancy Gorgi; Niree Kalfayan; Elise M Gilbert; Viktorija O Barr; Michael G Ison; Milena M McLaughlin
Journal:  J Pharm Pract       Date:  2018-09-04

10.  Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone.

Authors:  Tahia D Fernández; Adriana Ariza; Francisca Palomares; María I Montañez; María Salas; Angela Martín-Serrano; Rubén Fernández; Arturo Ruiz; Miguel Blanca; Cristobalina Mayorga; María J Torres
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.